首页|抗菌肽Dermaseptin-PP协同化疗药物抗肿瘤并逆转A549/DDP细胞顺铂耐药性

抗菌肽Dermaseptin-PP协同化疗药物抗肿瘤并逆转A549/DDP细胞顺铂耐药性

扫码查看
目的:探究抗菌肽Dermaseptin-PP对多种化疗药物体外抗肿瘤活性的协同增效作用,以及其对人非小细胞肺癌顺铂(DDP)耐药细胞株A549/DDP耐药性的逆转作用,并进一步探究其作用机制.方法:采用噻唑蓝(MTT)染色法检测不同质量浓度的Dermaseptin-PP对人非小细胞肺癌A549、H157 细胞或小鼠乳腺癌 4T1 细胞的增殖抑制作用,考察低毒质量浓度Dermaseptin-PP与多烯紫杉醇(DTX)、阿霉素(DOX)或DDP联用对A549、H157 或 4T1 细胞的协同抗肿瘤作用;采用细胞计数试剂盒-8(CCK-8)法检测低毒质量浓度Dermaseptin-PP对A549/DDP细胞DDP耐药性的逆转作用.采用流式细胞术检测Dermaseptin-PP对DDP诱导A549 细胞凋亡的影响,采用乳酸脱氢酶(LDH)释放实验及碘化丙啶(PI)摄取实验考察Dermaseptin-PP对A549 和A549/DDP细胞膜完整性的影响,最后通过扫描电镜观察Dermaseptin-PP处理后A549 和A549/DDP细胞膜形态的变化.结果:Dermaseptin-PP 可在体外抑制 A549、H157 和 4T1 细胞增殖且呈剂量依赖性;与低毒质量浓度 Dermaseptin-PP(0.002、0.020、0.200 μg·mL-1)联用后,DTX、DOX及DDP对A549 细胞的增殖抑制率均有不同程度的提高,半数抑制浓度(IC50)均有所降低,药物联合指数(CI)基本均小于 0.9,其中Dermaseptin-PP与DDP的协同作用最强(CI<0.4).此外,Dermaseptin-PP与DDP联用对H157 和 4T1 细胞的CI也均小于 0.9,表现为协同作用.低毒质量浓度Dermaseptin-PP(0.2、2.0、4.0 μg·mL-1)均能显著逆转A549/DDP细胞的DDP耐药性,逆转倍数(RF)分别为 2.83、5.09、9.73.相比于单用DDP,与 0.2 μg·mL-1 Dermaseptin-PP联用可显著提高A549 细胞的凋亡率(P<0.05);不同质量浓度的Dermaseptin-PP均可显著增加A549、A549/DDP细胞的LDH释放率和PI摄取率,且呈浓度依赖性;扫描电镜观察发现,经 2×IC50 的Dermaseptin-PP处理后,A549 细胞的细胞膜明显受损、质膜解体、细胞形态发生改变,A549/DDP细胞的细胞膜也出现明显孔洞.结论:Dermaseptin-PP对多种化疗药物体外抗肿瘤活性均具有协同增效作用,其中与DDP的协同作用最强,并且能够逆转A549/DDP细胞的DDP耐药性,其增效及逆转耐药的机制可能与破坏肿瘤细胞膜,进而提高化疗药物入胞药量有关.
Dermaseptin-PP Combined with Chemotherapeutic Agents Treats Tumors and Reverses Cisplatin Resistance of A549/DDP Cells
Objective:To investigate the effects of the antimicrobial peptide Dermaseptin-PP combined with chemotherapeutic agents on the tumor cells in vitro and the cisplatin(DDP)resistance of A549/DDP cells,and further explore the underlying mechanisms.Methods:The methyl thiazolyl tetrazolium(MTT)assay was employed to determine the inhibitory effects of different concentrations of Dermaseptin-PP on the proliferation of A549,H157 or 4T1 cells and the inhibitory effects of low concentrations of Dermaseptin-PP in combination with docetaxel(DTX),doxorubicin(DOX)or DDP on A549,H157 or 4T1 cells.The cell-counting kit 8(CCK-8)assay was used to determine the reversal effects of low concentrations of Dermaseptin-PP on the DDP resistance of A549/DDP cells.Flow cytometry was employed to measure the effect of Dermaseptin-PP on DDP-induced apoptosis of A549 cells.The lactate dehydrogenase(LDH)release assay and propidium iodide(PI)uptake assay were employed to investigate the effect of Dermaseptin-PP on the membrane integrity of A549 and A549/DDP cells.Finally,the morphological changes of A549 and A549/DDP cell membranes after Dermaseptin-PP treatment were observed by scanning electron microscopy.Results:Dermaseptin-PP inhibited the proliferation of A549,H157,and 4T1 cells in vitro in a dose-dependent manner.In combination with low concentrations(0.002,0.020,and 0.200 μg·mL-1)of Dermaseptin-PP,DTX,DOX,and DDP demonstrated increased inhibition rates on the proliferation of A549 cells,with reduced half maximal inhibitory concentrations(IC50)and the combination indexes(CIs)lower than 0.9.The combination of Dermaseptin-PP with DDP demonstrated the strongest synergistic effect(CI<0.4).In addition,Dermaseptin-PP combined with DDP showed a synergistic effect,with the CIs lower than 0.9 for both H157 and 4T1 cells.Low concentrations(0.2,2.0,and 4.0 μg·mL-1)of Dermaseptin-PP all significantly reversed the DDP resistance of A549/DDP cells,with the reversal folds(RFs)of 2.83,5.09,and 9.73,respectively.Compared with DDP alone,the combination of DDP with 0.2 μg·mL-1 Dermaseptin-PP increased the apoptosis rate of A549 cells(P<0.05).Dermaseptin-PP increased the LDH release rate and PI uptake rate of A549 and A549/DDP cells in a concentration-dependent manner.The treatment with Dermaseptin-PP at a concentration of 2×IC50 damaged the cell membranes,disintegrated the plasma membranes,and altered the morphology of A549 cells,and the treatment led to the appearance of holes in the cell membranes of A549/DDP cells.Conclusion:Dermaseptin-PP combined with chemotherapeutic agents demonstrated synergistic effects on the tumor cells in vitro,among which the synergistic effect with DDP was the strongest.Moreover,Dermaseptin-PP can reverse the DDP resistance of A549/DDP cells by directly destroying the cell membrane to improve the amount of chemotherapeutic agents entering the cells.

antimicrobial peptidesDermaseptin-PPchemotherapyanti-tumordrug resistancecisplatin(DDP)

闫丽文、胡祖成、彭凤栖、胡文均、胡海燕、陈基杰、陆洋

展开 >

北京中医药大学 中药学院,北京 102488

泰国国立法政大学 朱拉蓬国际医学院,巴吞他尼府 12120

抗菌肽 Dermaseptin-PP 化疗 抗肿瘤 耐药 顺铂

国家中医药管理局高水平中医药重点学科建设项目

zyyzdxk-2023272

2024

中国现代中药
中国中药协会,中国医药集团总公司,中国药材公司

中国现代中药

CSTPCD
影响因子:0.65
ISSN:1673-4890
年,卷(期):2024.26(10)